LIFECOME(SZ:002868) Zheng Quan Zhi Xing·2025-06-27 16:48Core Viewpoint - The board of directors of Green康 Biochemical Co., Ltd. confirms that the parties involved in the proposed transaction do not fall under the prohibitions outlined in the regulatory guidelines regarding abnormal trading related to major asset restructuring [1][2] Group 1: Transaction Details - Green康 Biochemical Co., Ltd. plans to sell 100% equity stakes in three subsidiaries: Green康 (Yushan) Film Material Co., Ltd., Green康 (Haining) Film Material Co., Ltd., and Green康 New Energy (Shanghai) Import and Export Trade Co., Ltd. for cash [1] - The transaction is subject to the regulations set forth in the "Guidelines for the Supervision of Listed Companies No. 7" regarding major asset restructuring [1] Group 2: Compliance and Investigation Status - The company, the counterparty, and related parties, including controlling shareholders and management, have not been investigated or prosecuted for insider trading related to major asset restructuring in the last 36 months [1][2] - There are no administrative penalties or criminal responsibilities imposed by the China Securities Regulatory Commission related to insider trading for the involved parties in the specified timeframe [1][2]